

KLIKJARO (TIRZEPATIDE) 40mg is offered as a 40mg catalogue option for laboratory research. Researchers can view the supplied original laboratory report via a linked Certificate of Analysis to verify the material and batch. It is important to ensure the report matches the specific material and batch required for your research work. This product is intended solely for laboratory research and is not for human or animal consumption.
Every Evora batch is third-party tested before release. See the certificate of analysis on our COAs page.
Loading reviews…
Choose the right injection area
Use the abdomen or the upper legs. Divide the area you choose into four sections and move to a new section each week, so the same spot is not used again too soon.
- Abdomen or upper legs
- Switch injection sites weekly
- At least one finger width from the last injection
- At least 5 cm away from the navel
General guidance only. Always follow the instructions supplied with your product.
UK delivery is a flat £10.00 with tracking (international £35.00). Orders placed before 2pm Monday to Friday are dispatched the same day.
International shipping is available to selected countries. See our shipping policy for details.
KLIKJARO (TIRZEPATIDE) 40mg: product information
KLIKJARO is Evora's tirzepatide product, available in 40mg and 60mg. Tirzepatide (research code LY3298176) is a synthetic peptide that acts on two receptors, GIP and GLP-1, which is why it is described as a dual agonist. It has been studied in the SURPASS and SURMOUNT clinical trial programmes. KLIKJARO is supplied as a research compound: it is not a licensed medicine and is not made by any pharmaceutical brand-name manufacturer.
Frequently asked questions
What is KLIKJARO?
What is tirzepatide?
Tirzepatide vs semaglutide?
Is KLIKJARO a licensed medicine?
Is there a certificate of analysis?
How should it be stored?
How much is delivery?
Related products: KLIKJARO (TIRZEPATIDE) 60mg · RETATRUTIDE 40mg · KLIKTIDE (CAGRILINTIDE) 10mg · RETATRUTIDE 20mg · Lab reports (COAs)


